Skip to main content
profile image
Selected Works of Zeus Antonello
Article
Pericytes elicit resistance to vemurafenib and sorafenib therapy in thyroid carcinoma via the TSP-1/TGFβ1 axis
Clinical Cancer Research (2018)
  • Alessandro Prete, Harvard University
  • Agnes Sy Lo
  • Peter M Sadow, Harvard University
  • Swati S. Bhasin, Harvard University
  • Zeus A. Antonello, Cooper University Hospital
  • Danica M. Vodopivec, Harvard University
  • Soumya Ullas, Roswell Park Cancer Institute
  • Jennifer N. Sims, Jackson State University
  • John G. Clohessy, Beth Israel Deaconess Medical Center
  • Ann M Dvorak, Harvard University
  • Tracey Sciuto, Beth Israel Deaconess Medical Center
  • Manoj Bhasin, Beth Israel Deaconess Medical Center
  • Joanne E. Murphy-Ullrich, University of Alabama at Birmingham
  • Jack Lawler, Beth Israel Deaconess Medical Center
  • S. Ananth Karumanchi, Beth Israel Deaconess Medical Center
  • Carmelo Nucera, Beth Israel Deaconess Medical Center
Link
Disciplines
Publication Date
August 3, 2018
DOI
10.1158/1078-0432.ccr-18-0693
Citation Information
Alessandro Prete, Agnes Sy Lo, Peter M Sadow, Swati S. Bhasin, et al.. "Pericytes elicit resistance to vemurafenib and sorafenib therapy in thyroid carcinoma via the TSP-1/TGFβ1 axis" Clinical Cancer Research (2018)
Available at: http://works.bepress.com/zeus-antonello/4/